0001871839-21-000001.txt : 20210709 0001871839-21-000001.hdr.sgml : 20210709 20210709132016 ACCESSION NUMBER: 0001871839-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 EFFECTIVENESS DATE: 20210709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fuse Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001871839 IRS NUMBER: 861898312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-405726 FILM NUMBER: 211082317 BUSINESS ADDRESS: STREET 1: 6080 CENTER DRIVE STREET 2: 6TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3109918254 MAIL ADDRESS: STREET 1: 6080 CENTER DRIVE STREET 2: 6TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90045 D 1 primary_doc.xml X0708 D LIVE 0001871839 Fuse Biotherapeutics, Inc. 6080 CENTER DRIVE 6TH FLOOR LOS ANGELES CA CALIFORNIA 90045 3109918254 DELAWARE None None Corporation true 2021 Paul Song 6080 Center Drive 6th Floor Los Angeles CA CALIFORNIA 90045 Executive Officer Director Brian Rabinovich 6080 Center Drive 6th Floor Los Angeles CA CALIFORNIA 90045 Executive Officer Director Jeffrey Takimoto 6080 Center Drive 6th Floor Los Angeles CA CALIFORNIA 90045 Executive Officer Yuanheng Wang Liang 6080 Center Drive 6th Floor Los Angeles CA CALIFORNIA 90045 Director Pharmaceuticals Decline to Disclose 06b false 2021-06-24 false true false 0 7074999 2624997 4450002 false 5 0 0 0 false Fuse Biotherapeutics, Inc. /s/Paul Y. Song Paul Y. Song Chief Executive Officer 2021-07-09